Alimera Sciences Inc (NASDAQ:ALIM)

1.12
Delayed Data
As of Apr 18
 +0.01 / +0.90%
Today’s Change
1.00
Today|||52-Week Range
1.70
-15.79%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.11
Today’s open1.10
Day’s range1.10 - 1.13
Volume59,103
Average volume (3 months)136,372
Market cap$77.7M
Data as of 4:00pm ET, 04/18/2018

Growth & Valuation

Earnings growth (last year)+47.62%
Earnings growth (this year)+54.19%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+4.60%
P/E ratioNM
Price/Sales2.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc+0.02+0.95%
SYNSynthetic Biologics ...-0.02-4.53%
VVUSVIVUS Inc+0.02+4.11%
ZFGNZafgen Inc-0.19-2.62%
Data as of 8:00pm ET, 04/18/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$35.9M
Annual profit (last year)-$22.0M
Net profit margin-61.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts